Insider Transactions in Q1 2025 at Akoya Biosciences, Inc. (AKYA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2025
|
Jennifer Kamocsay Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,445
-2.01%
|
$7,445
$1.63 P/Share
|
|
Mar 01
2025
|
John Frederick Ek CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,594
-1.34%
|
$3,594
$1.63 P/Share
|
|
Mar 01
2025
|
Pascal Bamford Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,850
-0.92%
|
$3,850
$1.63 P/Share
|
|
Mar 01
2025
|
Niro Ph.D Ramachandran Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,904
-1.0%
|
$5,904
$1.63 P/Share
|
|
Mar 01
2025
|
Brian Mc Kelligon President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,807
-1.8%
|
$15,807
$1.63 P/Share
|